Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Neuropathies among HIV patients have continued to increase in recent years, particularly in the case of antiretroviral toxic neuropathy (ATN). Investigators have focused on developing three different types of treatments for HIV-associated neuropathies.

New advances promising in treating neuropathy